NINDS Division Translational Research – Rodent Pharmacokinetic (PK) Studies
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N95024R00062
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Bethesda, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse is seeking proposals for Rodent Pharmacokinetic (PK) Testing Services through a competitive solicitation. The contractor must conduct plasma and brain sample analysis, as well as rodent PK studies, to assess blood and tissue levels of novel test articles provided by the Government. Key requirements include FDA compliance, an approved Animal Welfare Assurance, and AAALAC accreditation. Technical evaluation factors focus on the offeror's technical approach, management and staffing plan, and the acceptability of their vertebrate animal use plan. Proposals are due by July 29, 2024, and award will be made to the responsible offeror whose proposal provides the best overall value to the Government, with technical factors being significantly more important than cost.
This solicitation does not have any set-aside designations. The Government did not provide any information about potential incumbents or the anticipated award value range. The contract has a 12-month period of performance with the possibility of up to 5 option periods for additional rodent PK studies. The place of performance is Bethesda, MD.
Notice text
2 versions
Update #2 · Latest ·
Amendment 1
NINDS Division Translational Research – Rodent Pharmacokinetic (PK) Testing Services
The purpose of this amendment is to replace Attachment 1: Statement of Work, with the revised, Attachment 1: Statement of Work, Amendment I, dated July 24, 2024.
Please see the revisions highlighted in yellow in the attachment, Statement of Work, Amendment I
There is no extension to the offer due date. Offers are due July 29, 2024 11:00 am EDT.
-----------------------
COMBINED SYNOPSIS / SOLICITATION
COMPETITIVE
Title: NINDS Division Translational Research – Rodent Pharmacokinetic (PK) Testing Services
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
**PLEASE SEE ATTACHMENTS FOR ADDITIONAL INFORMATION.**
Attachments:
Combined Synopsis Solicitation
Attachment 1 – Statement of Work
Attachment 2 – Technical Evaluation Criteria
Attachment 3 – Terms & Conditions
Attachment 4 – FAR 52.212-5
Attachment 5 – VAS Worksheet
Attachment 6 – Invoice Instructions
Update #1 ·
COMBINED SYNOPSIS / SOLICITATION
COMPETITIVE
Title: NINDS Division Translational Research – Rodent Pharmacokinetic (PK) Testing Services
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
**PLEASE SEE ATTACHMENTS FOR ADDITIONAL INFORMATION.**
Attachments:
Combined Synopsis Solicitation
Attachment 1 – Statement of Work
Attachment 2 – Technical Evaluation Criteria
Attachment 3 – Terms & Conditions
Attachment 4 – FAR 52.212-5
Attachment 5 – VAS Worksheet
Attachment 6 – Invoice Instructions
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| NINDS Division Translational Research – Rodent Pharmacokinetic (PK) Studies | Award Notice | |
| This notice | Solicitation | |
| NINDS Division Translational Research – Rodent Pharmacokinetic (PK) Studies | Pre-Solicitation | |
| Request for Information (RFI) - NINDS Division Translational Research – Continuous Rodent and Non-Rodent Pharmacokinetic (PK) Assessments | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Best Pharmaceuticals for Children Act Data Coordination Center | National Institute of Child Health and Human Development | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity